Longeveron adds orthopedic surgeon George Paletta to board
Get Alerts LGVN Hot Sheet
Join SI Premium – FREE
Longeveron Inc. (NASDAQ: LGVN) announced that George Paletta Jr., MD, MBA, has been elected to its board of directors. Paletta serves as head team doctor for the St. Louis Cardinals and is an orthopedic surgeon with experience in developing ambulatory surgical centers.
The Miami-based biotechnology company develops cellular therapies for pediatric and aging-related conditions. Paletta has participated in the sale of two ambulatory surgical centers with combined deal values of nearly $1 billion, according to the company.
"His broad experience across multiple business areas will bring significant value to Longeveron as we continue to advance our stem cell therapies," said Joshua Hare, co-founder and executive chairman of Longeveron's board.
Paletta holds multiple patents in orthopedic and cardiovascular areas and founded Preston Worldwide, a medical device company. He has served as an early-stage investor in various startup ventures across different industries.
The surgeon received his medical degree from Johns Hopkins University School of Medicine and completed his orthopedic residency at Hospital for Special Surgery in New York City. He earned an MBA from Washington University's Olin School of Business.
Longeveron's lead investigational product is laromestrocel, a mesenchymal stem cell therapy derived from bone marrow of adult donors. The company is pursuing treatments for hypoplastic left heart syndrome, Alzheimer's disease, pediatric dilated cardiomyopathy and aging-related frailty.
The company's hypoplastic left heart syndrome program has received FDA orphan drug, fast track and rare pediatric disease designations. Its Alzheimer's program has received regenerative medicine advanced therapy and fast track designations from the FDA.
You May Also Be Interested In
- Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
- Lode Gold names Qi Guo to its board of directors
- Bausch + Lomb names Appio as chairman, reshapes board committees
Create E-mail Alert Related Categories
Board ChangesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share